Erythropoietin Terminated Phase 4 Trials for Anemia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02624141A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy
NCT02608060A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B
NCT01737879Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis
NCT00511901Prevalence and Treatment of Anemia in Rehabilitation Patients
NCT00440063A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
NCT00211120Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)